Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPCC
3601
DELISTED
Infinity Property & Casualty C
IPCC
| $1.84M | ﹤0.01% |
17,339
+7,310
| +73% | +$743K |
|
3602
CALL
Gray Television
GTN
$520M
| $1.84M | ﹤0.01% |
109,700
+77,000
| +235% | +$1.2M |
|
3603
CALL
Myriad Genetics
MYGN
$303M
| $1.84M | ﹤0.01% |
53,500
+19,800
| +59% | +$668K |
|
3604
CALL
Universal Health Services
UHS
$10.1B
| $1.84M | ﹤0.01% |
16,200
-7,700
| -32% | -$823K |
|
3605
PUT
Ryanair
RYAAY
$30.7B
| $1.83M | ﹤0.01% |
44,000
+7,500
| +21% | +$334K |
|
3606
iShares GNMA Bond ETF
GNMA
$433M
| $1.83M | ﹤0.01% |
+37,021
| New | +$1.84M |
|
3607
Hudbay
HBM
$11.8B
| $1.83M | ﹤0.01% |
208,200
+178,125
| +592% | +$1.39M |
|
3608
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $1.83M | ﹤0.01% |
40,832
-70,476
| -63% | -$3M |
|
|
FPRX
3609
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.83M | ﹤0.01% |
+83,284
| New | +$2.68M |
|
|
DCOM
3610
DELISTED
Dime Community Bancshares
DCOM
| $1.83M | ﹤0.01% |
87,161
+29,068
| +50% | +$622K |
|
3611
Cerus
CERS
$572M
| $1.82M | ﹤0.01% |
539,948
-393,141
| -42% | -$1.33M |
|
3612
A10 Networks
ATEN
$1.96B
| $1.82M | ﹤0.01% |
236,082
-165,531
| -41% | -$1.26M |
|
|
GREK
3613
PUT
Global X MSCI Greece ETF
GREK
$331M
| $1.82M | ﹤0.01% |
59,067
+38,700
| +190% | +$1.09M |
|
3614
Fidelity High Dividend ETF
FDVV
$10.5B
| $1.82M | ﹤0.01% |
+63,431
| New | +$1.77M |
|
3615
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
| $1.82M | ﹤0.01% |
40,508
+33,492
| +477% | +$1.5M |
|
|
QTNA
3616
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $1.82M | ﹤0.01% |
149,001
+106,255
| +249% | +$1.45M |
|
3617
CALL
Agilent Technologies
A
$42.2B
| $1.81M | ﹤0.01% |
27,100
-16,700
| -38% | -$1.13M |
|
3618
Houlihan Lokey
HLI
$9.24B
| $1.81M | ﹤0.01% |
+39,914
| New | +$1.71M |
|
3619
Invesco Preferred ETF
PGX
$3.77B
| $1.81M | ﹤0.01% |
+121,879
| New | +$1.83M |
|
3620
PUT
HDFC Bank
HDB
$119B
| $1.81M | ﹤0.01% |
71,200
+32,400
| +84% | +$776K |
|
|
CNCE
3621
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.81M | ﹤0.01% |
69,961
-54,718
| -44% | -$1.1M |
|
3622
PUT
Acadia Pharmaceuticals
ACAD
$4.89B
| $1.81M | ﹤0.01% |
60,000
+20,500
| +52% | +$656K |
|
3623
CBRE Group
CBRE
$44B
| $1.81M | ﹤0.01% |
41,689
-922,462
| -96% | -$38.2M |
|
|
P
3624
PUT
Everpure Inc
P
$39B
| $1.81M | ﹤0.01% |
113,900
+81,400
| +250% | +$1.36M |
|
3625
CALL
Direxion Daily Technology Bull 3x ETF
TECL
$6.47B
| $1.81M | ﹤0.01% |
161,000
+86,000
| +115% | +$916K |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.